No Data
No Data
XORTX Initiates Precision Medicine Program
XORTX Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
XORTX Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)
XORTX Therapeutics Shareholders Approve Key Decisions
XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders
No Data
No Data